These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36920835)
1. Amitriptyline, Duloxetine, and Pregabalin Each Effective in Decreasing Pain From Diabetic Peripheral Neuropathy; Combinations Even Better. Barry HC Am Fam Physician; 2023 Mar; 107(3):316-317. PubMed ID: 36920835 [No Abstract] [Full Text] [Related]
2. Combination therapy for painful diabetic neuropathy is safe and effective. Saul H; Deeney B; Imison C; Tesfaye S BMJ; 2023 Apr; 381():866. PubMed ID: 37085164 [TBL] [Abstract][Full Text] [Related]
3. Amitriptyline, Pregabalin and Duloxetine for Treatment of Painful Diabetic Peripheral Neuropathy. Nepal R; Bajracharya MR; Karki BB; Mall D; Shrestha PS; Wasti KP; Bisht A J Nepal Health Res Counc; 2024 Jun; 22(1):185-191. PubMed ID: 39080958 [TBL] [Abstract][Full Text] [Related]
4. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S; Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206 [TBL] [Abstract][Full Text] [Related]
5. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation. Carlos F; Espejel L; Novick D; López R; Flores D Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study. Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266 [TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review. Hossain SM; Hussain SM; Ekram AR Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221 [TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study. Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665 [TBL] [Abstract][Full Text] [Related]
10. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine. Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173 [TBL] [Abstract][Full Text] [Related]
11. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy? Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228 [TBL] [Abstract][Full Text] [Related]
13. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis. van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034 [TBL] [Abstract][Full Text] [Related]
14. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Bellows BK; Nelson RE; Oderda GM; LaFleur J Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932 [TBL] [Abstract][Full Text] [Related]
15. Diabetic Peripheral Neuropathy: Prevention and Treatment. Bragg S; Marrison ST; Haley S Am Fam Physician; 2024 Mar; 109(3):226-232. PubMed ID: 38574212 [TBL] [Abstract][Full Text] [Related]
16. Drug combinations in diabetic neuropathic pain: an experimental validation. Tripathi CD; Mehta AK; Yadav AM J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):617-624. PubMed ID: 27331307 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update. Rafiullah M; Siddiqui K CNS Neurol Disord Drug Targets; 2022; 21(10):884-900. PubMed ID: 33655879 [TBL] [Abstract][Full Text] [Related]
18. [Medical Treatment of Chronic Pain]. Nodera H Brain Nerve; 2023 Mar; 75(3):227-234. PubMed ID: 36890758 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189 [TBL] [Abstract][Full Text] [Related]
20. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model. Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]